Naotoshi Sugimoto

14.5k total citations · 4 hit papers
242 papers, 9.1k citations indexed

About

Naotoshi Sugimoto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Naotoshi Sugimoto has authored 242 papers receiving a total of 9.1k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Pulmonary and Respiratory Medicine, 90 papers in Oncology and 60 papers in Molecular Biology. Recurrent topics in Naotoshi Sugimoto's work include Gastric Cancer Management and Outcomes (67 papers), Colorectal Cancer Treatments and Studies (50 papers) and Lung Cancer Treatments and Mutations (24 papers). Naotoshi Sugimoto is often cited by papers focused on Gastric Cancer Management and Outcomes (67 papers), Colorectal Cancer Treatments and Studies (50 papers) and Lung Cancer Treatments and Mutations (24 papers). Naotoshi Sugimoto collaborates with scholars based in Japan, United States and South Korea. Naotoshi Sugimoto's co-authors include Yoh Takuwa, Noriko Takuwa, Sotaro Sakurada, Hiroyuki Okamoto, Osamu Shido, Shuichi Hironaka, Andrej A. Romanovsky, Yoshito Komatsu, Kei Muro and Atsushi Ohtsu and has published in prestigious journals such as New England Journal of Medicine, Cell and Journal of Biological Chemistry.

In The Last Decade

Naotoshi Sugimoto

230 papers receiving 8.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

2014 1.7k citations Kei Muro, Yasuhiro Shimada et al. profile →
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

2020 802 citations Kohei Shitara, Yung‐Jue Bang et al. profile →
Divergent Signals and Cytoskeletal Assemblies Regulate Self-Organizing Polarity in Neutrophils

2003 552 citations Naotoshi Sugimoto et al. profile →
Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

2013 351 citations Shuichi Hironaka, Hirofumi Yasui et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Naotoshi Sugimoto

Since Specialization

Citations

This map shows the geographic impact of Naotoshi Sugimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naotoshi Sugimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naotoshi Sugimoto more than expected).

Fields of papers citing papers by Naotoshi Sugimoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naotoshi Sugimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naotoshi Sugimoto. The network helps show where Naotoshi Sugimoto may publish in the future.

Co-authorship network of co-authors of Naotoshi Sugimoto

This figure shows the co-authorship network connecting the top 25 collaborators of Naotoshi Sugimoto. A scholar is included among the top collaborators of Naotoshi Sugimoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naotoshi Sugimoto. Naotoshi Sugimoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Study (NO LIMIT, WJOG13320G) of First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability–High Advanced Gastric or Esophagogastric Junction Cancer 2025 ·Journal of Clinical Oncology ·Hisato Kawakami, Shigenori Kadowaki, Akitaka Makiyama, Masahiro Tsuda, Kenro Hirata, Naotoshi Sugimoto, Nozomu Machida, Hiroki Hara, Hidekazu Hirano, Taito Esaki, Yoshito Komatsu, Shuichi Hironaka, Yukari Kobayashi, Kazuhiro Kakimi, Yasutaka Chiba, Narikazu Boku, Ichinosuke Hyodo, (unknown)	2
2	Prognostic factors and treatment response in HER2-positive gastric cancer patients receiving trastuzumab deruxtecan: secondary analysis of the EN-DEAVOR study 2025 ·PubMed ·Koki Nakanishi, Naotoshi Sugimoto, Yasuhiro Kodera, (unknown), Akitaka Makiyama, Hirotaka Konishi, Satoshi Morita, Yukiya Narita, Keiko Minashi, Motohiro Imano, (unknown), (unknown), (unknown), Mari Hagiwara, (unknown), Kensei Yamaguchi, Wataru Hashimoto, (unknown)	0
3	Short-term outcomes of a phase II trial of perioperative capecitabine plus oxaliplatin therapy for advanced gastric cancer with extensive lymph node metastases (OGSG1701) 2024 ·Gastric Cancer ·Yutaka Kimura, Naotoshi Sugimoto, Shunji Endo, Ryohei Kawabata, Jin Matsuyama, Atsushi Takeno, Masato Nakamura, Hiroki Takeshita, Hironaga Satake, Shigeyuki Tamura, Daisuke Sakai, Hisato Kawakami, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh	0
4	Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication 2024 ·Frontiers in Immunology ·(unknown), Hiroshi Tsujimoto, Tadafumi Yokoyama, Naotoshi Sugimoto, Shinji Kitajima, Hiroshi Fujii, Yoshihiko Hidaka, Noritoshi Kato, Shoichi Maruyama, Norimitsu Inoue, Taizo Wada	1
5	Utility of Comprehensive Genomic Profiling Tests for Patients with Incurable Pancreatic Cancer in Clinical Practice 2023 ·Cancers ·Takuo Yamai, Kenji Ikezawa, Naotoshi Sugimoto, (unknown), Yugo Kai, Ryoji Takada, Tasuku Nakabori, Hiroyuki Uehara, Takahisa Kawamura, Kei Kunimasa, (unknown), Toru Wakamatsu, Takuji Hayashi, (unknown), (unknown), (unknown), (unknown), Tomoyuki Yamasaki, Keiichiro Honma, Kazuyoshi Ohkawa	13
6	Clinical development and evaluation of plasma angiogenesis factors from phase II study of FOLFIRI plus ramucirumab with recurrent colorectal cancer refractory to adjuvant chemotherapy with oxaliplatin/fluoropyrimidine (RAINCLOUD): RAINCLOUD-TR. 2023 ·Journal of Clinical Oncology ·Tsuyoshi Hata, Naotoshi Sugimoto, (unknown), (unknown), Shinichi Yoshioka, Yoshinori Kagawa, Atsushi Naito, Mitsuyoshi Tei, (unknown), (unknown), (unknown), Katsuki Danno, Toshio Shimokawa, (unknown), Norikatsu Miyoshi, (unknown), (unknown), Kohei Murata, Yuichiro� Doki, Hidetoshi Eguchi	1
7	Trastuzumab Deruxtecan in Anti–Human Epidermal Growth Factor Receptor 2 Treatment–Naive Patients With Human Epidermal Growth Factor Receptor 2–Low Gastric or Gastroesophageal Junction Adenocarcinoma: Exploratory Cohort Results in a Phase II Trial 2022 ·Journal of Clinical Oncology ·Kensei Yamaguchi, Yung‐Jue Bang, Satoru Iwasa, Naotoshi Sugimoto, Min‐Hee Ryu, Daisuke Sakai, Hyun Cheol Chung, Hisato Kawakami, Hiroshi Yabusaki, Jeeyun Lee, Tatsu Shimoyama, Keun‐Wook Lee, Kaku Saito, Yoshinori Kawaguchi, Takahiro Kamio, (unknown), Masahiro Sugihara, Kohei Shitara	76
8	An Investigator-Initiated Phase 2 Study of Nivolumab Plus Low-Dose Ipilimumab as First-Line Therapy for Microsatellite Instability—High Advanced Gastric or Esophagogastric Junction Cancer (NO LIMIT, WJOG13320G/CA209-7W7) 2021 ·Cancers ·Hisato Kawakami, Shuichi Hironaka, Taito Esaki, Kazuaki Chayama, Masahiro Tsuda, Naotoshi Sugimoto, Shigenori Kadowaki, Akitaka Makiyama, Nozomu Machida, Hidekazu Hirano, Kenro Hirata, Hiroki Hara, Hiroshi Yabusaki, Yoshito Komatsu, Kei Muro	14
9	Clinical Outcomes Following Trifluridine/Tipiracil Treatment for Patients With Metastatic Colorectal Cancer Ineligible for Regorafenib Treatment 2021 ·Anticancer Research ·(unknown), Toshikazu Moriwaki, Shota Fukuoka, Toshiki Masuishi, Atsuo Takashima, (unknown), Takeshi Kajiwara, Kentaro Yamazaki, Taito Esaki, Akitaka Makiyama, Tadamichi Denda, Yukimasa Hatachi, Takeshi Suto, Naotoshi Sugimoto, Yasuhiro Shimada	2
10	Evaluation of FOLFOX or CAPOX reintroduction with or without bevacizumab in relapsed colorectal cancer patients treated with oxaliplatin as adjuvant chemotherapy (REACT study) 2020 ·International Journal of Clinical Oncology ·Masahito Kotaka, Shigeyoshi Iwamoto, Hironaga Satake, Daisuke Sakai, Toshihiro Kudo, Mutsumi Fukunaga, (unknown), (unknown), (unknown), Akihito Tsuji, Yasushi Sano, Takeshi Kato, Naotoshi Sugimoto, Taroh Satoh, Akiyoshi Kanazawa, Takayasu Kurata, Takeharu Yamanaka, Naohiro Tomita	4
11	Quality of Life Associated with Ramucirumab Treatment in Patients with Advanced Gastric Cancer in Japan: Exploratory Analysis from the Phase III RAINBOW Trial 2020 ·Clinical Drug Investigation ·Kensei Yamaguchi, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Yoshito Komatsu, Tomohiro Nishina, Yasushi Omuro, Takao Tamura, Yongzhe Piao, (unknown), Min‐Hua Jen, Astra M. Liepa, Kei Muro	2
12	Comparison of S-1–cisplatin every 5 weeks with capecitabine-cisplatin every 3 weeks for HER2-negative gastric cancer (recurrent after S-1 adjuvant therapy or chemotherapy-naïve advanced): pooled analysis of HERBIS-2 (OGSG 1103) and HERBIS-4A (OGSG 1105) trials 2020 ·International Journal of Clinical Oncology ·Hisato Kawakami, Kazumasa Fujitani, Jin Matsuyama, Yusuke Akamaru, Shigeyuki Tamura, Shunji Endo, Yutaka Kimura, (unknown), Takao Tamura, Naotoshi Sugimoto, Daisuke Sakai, Toshimasa Tsujinaka, Masahiro Goto, Yukinori Kurokawa, Toshio Shimokawa, Taroh Satoh, (unknown)	5
13	Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802) 2020 ·International Journal of Clinical Oncology ·Takashi Ohta, Takeshi Kato, Hisato Kawakami, Yasuhiro Miyake, Masahiro Goto, Shigeyoshi Iwamoto, Toshio Otsuji, Masato Nakamura, Naotoshi Sugimoto, Shu Okamura, Masahito Kotaka, Masaki Tsujie, Yukihiko Tokunaga, Hideyuki Mishima, Taishi Hata, Toshio Shimokawa, Yukinori Kurokawa, Taroh Satoh	4
14	Sex differences in the safety of S‐1 plus oxaliplatin and S‐1 plus cisplatin for patients with metastatic gastric cancer 2019 ·Cancer Science ·Yasuhide Yamada, Wasaburo Koizumi, Kazuhiro Nishikawa, Masahiro Gotoh, Nozomu Fuse, Naotoshi Sugimoto, Tomohiro Nishina, Kenji Amagai, Keisho Chìn, Yasumasa Niwa, Akihito Tsuji, Hiroshi Imamura, Masahiro Tsuda, Hirofumi Yasui, Hirofumi Fujii, Kensei Yamaguchi, Hisateru Yasui, Shuichi Hironaka, Ken Shimada, Ichinosuke Hyodo	12
15	In vivo imaging of T cell lymphoma infiltration process at the colon 2018 ·Scientific Reports ·Yoshibumi Ueda, Toshiyuki Ishiwata, Seiichi Shinji, Tomio Arai, Yoko Matsuda, Junko Aida, Naotoshi Sugimoto, Toshiro Okazaki, Junichi Kikuta, Masaru Ishii, Moritoshi Sato	6
16	A Phase II Study of Gefitinib With Concurrent Thoracic Radiotherapy in Patients With Unresectable, Stage III Non–small-cell Lung Cancer Harboring EGFR Mutations (WJOG6911L) 2018 ·Clinical Lung Cancer ·Hiroaki Akamatsu, Hideyuki Harada, Shoji Tokunaga, Naruo Yoshimura, Hiroko Ikeda, Satoshi Oizumi, Naotoshi Sugimoto, Toshimi Takano, Haruyasu Murakami, Yasumasa Nishimura, Nobuyuki Yamamoto, Kazuhiko Nakagawa	18
17	Neuronal phenotype and responsiveness to heat of newborn neurons in the hypothalamus of heat-acclimated rats 2016 ·The Journal of Physiological Sciences ·Kentaro Matsuzaki, Masanori Katakura, Naotoshi Sugimoto, (unknown), Osamu Shido	1
18	Fluorescence-guided surgery of prostate cancer bone metastasis 2014 ·Journal of Surgical Research ·Shinji Miwa, Yasunori Matsumoto, Yukihiko Hiroshima, Shuya Yano, Fuminari Uehara, Mako Yamamoto, Yong Zhang, Hiroaki Kimura, Katsuhiro Hayashi, Norio Yamamoto, Michael Bouvet, Naotoshi Sugimoto, Hiroyuki Tsuchiya, Robert M. Hoffman	10
19	Image processing on regular coronary angiograms for myocardial perfusion measurements 2006 ·Computing in Cardiology Conference ·(unknown), Naotoshi Sugimoto, (unknown), (unknown), Akira Nakano, Masatoshi Fujita, Shigeru Eiho	2
20	A young female patient suffering from hypothermia in a cool environment 2002 ·(unknown), Naotoshi Sugimoto, Sotaro Sakurada, (unknown), Akira Asai, (unknown), Shoichi Koizumi	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact